Radiological assessment of skeletal muscle index and myosteatosis and their impact postoperative outcomes after liver transplantation

1. Starzl TE, Marchioro TL, Vonkaulla KN, Hermann G, Brittain RS, Waddell WR. Homotransplantation of the liver in humans. Surg Gynecol Obstet 1963; 117: 659–76. PMID: 14100514 StarzlTE MarchioroTL VonkaullaKN HermannG BrittainRS WaddellWR Homotransplantation of the liver in humans Surg Gynecol Obstet 1963 117 659 76 PMID: 14100514 Search in Google Scholar

2. Song AT, Avelino-Silva VI, Pecora RA, Pugliese V, D’Albuquerque LA, Abdala E. Liver transplantation: fifty years of experience. World J Gastroenterol 2014; 20: 5363–74. doi: 10.3748/wjg.v20.i18.5363 SongAT Avelino-SilvaVI PecoraRA PuglieseV D’AlbuquerqueLA AbdalaE Liver transplantation: fifty years of experience World J Gastroenterol 2014 20 5363 74 10.3748/wjg.v20.i18.5363 Open DOISearch in Google Scholar

3. Polyak A, Kuo A, Sundaram V. Evolution of liver transplant organ allocation policy: current limitations and future directions. World J Hepatol 2021; 13: 830–9. doi: 10.4254/with.v13.i8.830 PolyakA KuoA SundaramV Evolution of liver transplant organ allocation policy: current limitations and future directions World J Hepatol 2021 13 830 9 10.4254/with.v13.i8.830 Open DOISearch in Google Scholar

4. Deng M, Ng SWY, Cheung ST, Chong CCN. Clinical application of Albumin-Bilirubin (ALBI) scores: the current status. Surgeon 2020; 18: 178–86. doi: 10.1016/j.surge.2019.09.002 DengM NgSWY CheungST ChongCCN Clinical application of Albumin-Bilirubin (ALBI) scores: the current status Surgeon 2020 18 178 86 10.1016/j.surge.2019.09.002 Open DOISearch in Google Scholar

5. Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 2019; 48: 16–31. doi: 10.1093/ageing/afy169 Cruz-JentoftAJ BahatG BauerJ BoirieY BruyèreO CederholmT Sarcopenia: revised European consensus on definition and diagnosis Age Ageing 2019 48 16 31 10.1093/ageing/afy169 Open DOISearch in Google Scholar

6. Reginster JY, Beaudart C, Al-Daghri N, Avouac B, Bauer J, Bere N, et al. Update on the ESCEO recommendation for the conduct of clinical trials for drugs aiming at the treatment of sarcopenia in older adults. Aging Clin Exp Res 2021; 33: 3–17. doi: 10.1007/s40520-020-01663-4 ReginsterJY BeaudartC Al-DaghriN AvouacB BauerJ BereN Update on the ESCEO recommendation for the conduct of clinical trials for drugs aiming at the treatment of sarcopenia in older adults Aging Clin Exp Res 2021 33 3 17 10.1007/s40520-020-01663-4 Open DOISearch in Google Scholar

7. Delmonico MJ, Harris TB, Visser M, Park SW, Conroy MB, Velasquez-Mieyer P, et al. Health, aging, and body. Longitudinal study of muscle strength, quality, and adipose tissue infiltration. Am J Clin Nutr 2009; 90: 1579–85. doi: 10.3945/ajcn.2009.28047 DelmonicoMJ HarrisTB VisserM ParkSW ConroyMB Velasquez-MieyerP Health, aging, and body. Longitudinal study of muscle strength, quality, and adipose tissue infiltration Am J Clin Nutr 2009 90 1579 85 10.3945/ajcn.2009.28047 Open DOISearch in Google Scholar

8. Miljkovic I, Kuipers AL, Cvejkus R, Bunker CH, Patrick AL, Gordon CL, el al. Myosteatosis increases with aging and is associated with incident diabetes in African ancestry men. Obesity 2016; 24: 476–82. doi: 10.1002/oby.21328 MiljkovicI KuipersAL CvejkusR BunkerCH PatrickAL GordonCL Myosteatosis increases with aging and is associated with incident diabetes in African ancestry men Obesity 2016 24 476 82 10.1002/oby.21328 Open DOISearch in Google Scholar

9. Montano-Loza AJ, Angulo P, Meza-Junco J, Prado CM, Sawyer MB, Beaumont C, et al. Sarcopenic obesity and myosteatosis are associated with higher mortality in patients with cirrhosis. J Cachexia Sarcopenia Muscle 2015; 7: 126–35. doi: 10.1002/jcsm.12039 Montano-LozaAJ AnguloP Meza-JuncoJ PradoCM SawyerMB BeaumontC Sarcopenic obesity and myosteatosis are associated with higher mortality in patients with cirrhosis J Cachexia Sarcopenia Muscle 2015 7 126 35 10.1002/jcsm.12039 Open DOISearch in Google Scholar

10. Goodpaster BH, Theriault R, Watkins SC, Kelley DE. Intramuscular lipid content is increased in obesity and decreased by weight loss. Metabolism 2000; 49: 467–72. doi: 10.1016/s0026-0495(00)80010-4 GoodpasterBH TheriaultR WatkinsSC KelleyDE Intramuscular lipid content is increased in obesity and decreased by weight loss Metabolism 2000 49 467 72 10.1016/s0026-0495(00)80010-4 Open DOISearch in Google Scholar

11. Lee CM, Kang J. Prognostic impact of myosteatosis in patients with colorectal cancer: a systematic review and meta-analysis. J Cachexia Sarcopenia Muscle 2020; 11: 1270–82. doi: 10.1002/jcsm.12575 LeeCM KangJ Prognostic impact of myosteatosis in patients with colorectal cancer: a systematic review and meta-analysis J Cachexia Sarcopenia Muscle 2020 11 1270 82 10.1002/jcsm.12575 Open DOISearch in Google Scholar

12. Srpcic M, Jordan T, Popuri K, Sok M. Sarcopenia and myosteatosis at presentation adversely affect survival after esophagectomy for esophageal cancer. Radiol Oncol 2020; 54: 237–46. doi: 10.2478/raon-2020-0016 SrpcicM JordanT PopuriK SokM Sarcopenia and myosteatosis at presentation adversely affect survival after esophagectomy for esophageal cancer Radiol Oncol 2020 54 237 46 10.2478/raon-2020-0016 Open DOISearch in Google Scholar

13. Espinosa-Flores AJ, Guzman-Ortiz E, Melendez-Mier G, Ternovoy SK, Bueno-Hernandez N, Roldan-Valadez E. A scoping review of the methods used in patients with liver cirrhosis to assess body composition and their nutritional findings. [Ahead of print]. Eur J Clin Nutr 2023. doi:10.1038/s41430-023-01287-7 Espinosa-FloresAJ Guzman-OrtizE Melendez-MierG TernovoySK Bueno-HernandezN Roldan-ValadezE A scoping review of the methods used in patients with liver cirrhosis to assess body composition and their nutritional findings. [Ahead of print] Eur J Clin Nutr 2023 10.1038/s41430-023-01287-7 Open DOISearch in Google Scholar

14. Lee CM, Kang BK, Kim M. Radiologic definition of sarcopenia in chronic liver disease. Life (Basel) 2021; 11: 86. doi: 10.3390/life11020086 LeeCM KangBK KimM Radiologic definition of sarcopenia in chronic liver disease Life (Basel) 2021 11 86 10.3390/life11020086 Open DOISearch in Google Scholar

15. Kjønigsen LJ, Harneshaug M, Fløtten AM, Karterud LK, Petterson K, Skjolde G, et al. Reproducibility of semiautomated body composition segmentation of abdominal computed tomography: a multiobserver study. Eur Radiol Exp 2019; 3: 42. doi: 10.1186/s41747-019-0122-5 KjønigsenLJ HarneshaugM FløttenAM KarterudLK PettersonK SkjoldeG Reproducibility of semiautomated body composition segmentation of abdominal computed tomography: a multiobserver study Eur Radiol Exp 2019 3 42 10.1186/s41747-019-0122-5 Open DOISearch in Google Scholar

16. Jensen GL, Cederholm T, Correia MITD, Gonzalez MC, Fukushima R, Higashiguchi T, et al. GLIM criteria for the diagnosis of malnutrition: a consensus report from the global clinical nutrition community. JPEN J Parenter Enteral Nutr 2019; 43: 32–40. doi: 10.1002/jpen.1440 JensenGL CederholmT CorreiaMITD GonzalezMC FukushimaR HigashiguchiT GLIM criteria for the diagnosis of malnutrition: a consensus report from the global clinical nutrition community JPEN J Parenter Enteral Nutr 2019 43 32 40 10.1002/jpen.1440 Open DOISearch in Google Scholar

17. Song HN, Wang WB, Luo X, Huang DD, Ruan XJ, Xing CG, et al. Effect of GLIM-defined malnutrition on postoperative clinical outcomes in patients with colorectal cancer. Jpn J Clin Oncol 2022; 52: 466–74. doi: 10.1093/jjco/hyab215. SongHN WangWB LuoX HuangDD RuanXJ XingCG Effect of GLIM-defined malnutrition on postoperative clinical outcomes in patients with colorectal cancer Jpn J Clin Oncol 2022 52 466 74 10.1093/jjco/hyab215 Open DOISearch in Google Scholar

18. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004; 240: 205–13. doi: 10.1097/01.sla.0000133083.54934.ae DindoD DemartinesN ClavienPA Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey Ann Surg 2004 240 205 13 10.1097/01.sla.0000133083.54934.ae Open DOISearch in Google Scholar

19. Venturi C, Sempoux C, Bueno J, Ferreres Pinas JC, Bourdeaux C, Abarca-Quinones J, et al. Novel histologic scoring system for long-term allograft fibrosis after liver transplantation in children. Am J Transplant 2012; 12: 2986–96. doi: 10.1111/j.1600-6143.2012.04210.x VenturiC SempouxC BuenoJ Ferreres PinasJC BourdeauxC Abarca-QuinonesJ Novel histologic scoring system for long-term allograft fibrosis after liver transplantation in children Am J Transplant 2012 12 2986 96 10.1111/j.1600-6143.2012.04210.x Open DOISearch in Google Scholar

20. Popuri K, Cobzas D, Esfandiari N, Baracos V, Jagersand M. Body composition assessment in axial CT images using FEM-based automatic segmentation of skeletal muscle. IEEE Trans Med Imaging 2016; 35: 512–20. doi: 10.1109/TMI.2015.2479252 PopuriK CobzasD EsfandiariN BaracosV JagersandM Body composition assessment in axial CT images using FEM-based automatic segmentation of skeletal muscle IEEE Trans Med Imaging 2016 35 512 20 10.1109/TMI.2015.2479252 Open DOISearch in Google Scholar

21. van Vugt JL, Levolger S, de Bruin RW, van Rosmalen J, Metselaar HJ, IJzermans JN. Systematic review and meta-analysis of the impact of computed tomography-assessed skeletal muscle mass on outcome in patients awaiting or undergoing liver transplantation. Am J Transplant 2016; 16: 2277–92. doi: 10.1111/ajt.13732 van VugtJL LevolgerS de BruinRW van RosmalenJ MetselaarHJ IJzermansJN Systematic review and meta-analysis of the impact of computed tomography-assessed skeletal muscle mass on outcome in patients awaiting or undergoing liver transplantation Am J Transplant 2016 16 2277 92 10.1111/ajt.13732 Open DOISearch in Google Scholar

22. Ebadi M, Tsien C, Bhanji RA, Dunichand-Hoedl AR, Rider E, Motamedrad M, et al. Myosteatosis in cirrhosis: a review of diagnosis, pathophysiological mechanisms and potential interventions. Cells 2022; 11: 1216. doi: 10.3390/cells11071216 EbadiM TsienC BhanjiRA Dunichand-HoedlAR RiderE MotamedradM Myosteatosis in cirrhosis: a review of diagnosis, pathophysiological mechanisms and potential interventions Cells 2022 11 1216 10.3390/cells11071216 Open DOISearch in Google Scholar

23. Eslamparast T, Montano-Loza AJ, Raman M, Tandon P. Sarcopenic obesity in cirrhosis − the confluence of 2 prognostic titans. Liver Int 2018; 38: 1706–17. doi: 10.1111/liv.13876 EslamparastT Montano-LozaAJ RamanM TandonP Sarcopenic obesity in cirrhosis – the confluence of 2 prognostic titans Liver Int 2018 38 1706 17 10.1111/liv.13876 Open DOISearch in Google Scholar

24. Czigany Z, Kramp W, Bednarsch J, van der Kroft G, Boecker J, Strnad P, et al. Myosteatosis to predict inferior perioperative outcome in patients undergoing orthotopic liver transplantation. Am J Transplant 2020; 20: 493–503. doi: 10.1111/ajt.15577 CziganyZ KrampW BednarschJ van der KroftG BoeckerJ StrnadP Myosteatosis to predict inferior perioperative outcome in patients undergoing orthotopic liver transplantation Am J Transplant 2020 20 493 503 10.1111/ajt.15577 Open DOISearch in Google Scholar

25. Dasarathy S, Merli M. Sarcopenia from mechanism to diagnosis and treatment in liver disease. J Hepatol 2016; 65: 1232–44. doi: 10.1016/j.jhep.2016.07.040 DasarathyS MerliM Sarcopenia from mechanism to diagnosis and treatment in liver disease J Hepatol 2016 65 1232 44 10.1016/j.jhep.2016.07.040 Open DOISearch in Google Scholar

26. Ebadi M, Bhanji RA, Mazurak VC, Montano-Loza AJ. Sarcopenia in cirrhosis: from pathogenesis to interventions. J Gastroenterol 2019; 54: 845–59. doi:10.1007/s00535-019-01605-6 EbadiM BhanjiRA MazurakVC Montano-LozaAJ Sarcopenia in cirrhosis: from pathogenesis to interventions J Gastroenterol 2019 54 845 59 10.1007/s00535-019-01605-6 Open DOISearch in Google Scholar

27. Montano-Loza AJ. Skeletal muscle abnormalities and outcomes after liver transplantation. Liver Transpl 2014; 20: 1293–95. doi: 10.1002/lt.23995 Montano-LozaAJ Skeletal muscle abnormalities and outcomes after liver transplantation Liver Transpl 2014 20 1293 95 10.1002/lt.23995 Open DOISearch in Google Scholar

28. Kim HY, Jang JW. Sarcopenia in the prognosis of cirrhosis: going beyond the MELD score. World J Gastroenterol 2015; 21: 7637–47. doi: 10.3748/wjg.v21.i25.7637 KimHY JangJW Sarcopenia in the prognosis of cirrhosis: going beyond the MELD score World J Gastroenterol 2015 21 7637 47 10.3748/wjg.v21.i25.7637 Open DOISearch in Google Scholar

29. Levolger S, van Vugt JLA, de Bruin RWF, IJzermans JNM. Systematic review of sarcopenia in patients operated on for gastrointestinal and hepatopancreatobiliary malignancies. Br J Surg 2015, 102: 1448–58. doi: 10.1002/bjs.9893 LevolgerS van VugtJLA de BruinRWF IJzermansJNM Systematic review of sarcopenia in patients operated on for gastrointestinal and hepatopancreatobiliary malignancies Br J Surg 2015 102 1448 58 10.1002/bjs.9893 Open DOISearch in Google Scholar

30. Cao Q, Xiong Y, Zhong Z, Ye Q. Computed tomography-assessed sarcopenia indexes predict major complications following surgery for hepatopancreatobiliary malignancy: a meta-analysis. Ann Nutr Metab 2019; 74: 24–34. doi: 10.1159/000494887 CaoQ XiongY ZhongZ YeQ Computed tomography-assessed sarcopenia indexes predict major complications following surgery for hepatopancreatobiliary malignancy: a meta-analysis Ann Nutr Metab 2019 74 24 34 10.1159/000494887 Open DOISearch in Google Scholar

31. Kaibori M, Ishizaki M, Iida H, Matsui K, Sakaguchi T, Inoue K, et al. Effect of intramuscular adipose tissue content on prognosis in patients undergoing hepatocellular carcinoma resection. J Gastrointest Surg 2015; 19: 1315–23. doi: 10.1007/s11605-015-2838-8 KaiboriM IshizakiM IidaH MatsuiK SakaguchiT InoueK Effect of intramuscular adipose tissue content on prognosis in patients undergoing hepatocellular carcinoma resection J Gastrointest Surg 2015 19 1315 23 10.1007/s11605-015-2838-8 Open DOISearch in Google Scholar

32. Ooi PH, Hager A, Mazurak VC, Dajani K, Bhargava R, Gilmour SM, et al. Sarcopenia in chronic liver disease: impact on outcomes. Liver Transpl 2019; 25: 1422–38. doi: 10.1002/lt.25591 OoiPH HagerA MazurakVC DajaniK BhargavaR GilmourSM Sarcopenia in chronic liver disease: impact on outcomes Liver Transpl 2019 25 1422 38 10.1002/lt.25591 Open DOISearch in Google Scholar

33. Weerink LBM, van der Hoorn A, van Leeuwen BL, de Bock GH. Low skeletal muscle mass and postoperative morbidity in surgical oncology: a systematic review and meta-analysis. J Cachexia Sarcopenia Muscle 2020; 11: 636–49. doi: 10.1002/jcsm.12529 WeerinkLBM van der HoornA van LeeuwenBL de BockGH Low skeletal muscle mass and postoperative morbidity in surgical oncology: a systematic review and meta-analysis J Cachexia Sarcopenia Muscle 2020 11 636 49 10.1002/jcsm.12529 Open DOISearch in Google Scholar

34. Hsu CS, Kao JH. Sarcopenia and chronic liver diseases. Expert Rev Gastroenterol Hepatol 2018; 12: 1229–44. doi: 10.1080/17474124.2018.1534586 HsuCS KaoJH Sarcopenia and chronic liver diseases Expert Rev Gastroenterol Hepatol 2018 12 1229 44 10.1080/17474124.2018.1534586 Open DOISearch in Google Scholar

35. Pinto Dos Santos D, Kloeckner R, Koch S, Hoppe-Lotichius M, Zöller D, Toenges G, et al. Sarcopenia as prognostic factor for survival after orthotopic liver transplantation. Eur J Gastroenterol Hepatol 2020; 32: 626–34. doi: 10.1097/MEG.0000000000001552 Pinto Dos SantosD KloecknerR KochS Hoppe-LotichiusM ZöllerD ToengesG Sarcopenia as prognostic factor for survival after orthotopic liver transplantation Eur J Gastroenterol Hepatol 2020 32 626 34 10.1097/MEG.0000000000001552 Open DOISearch in Google Scholar

36. Montano-Loza AJ, Meza-Junco J, Prado CM, Lieffers JR, Baracos VE, Bain VG, et al. Muscle wasting is associated with mortality in patients with cirrhosis. Clin Gastroenterol Hepatol 2012; 10: 166–73, 173.e1. doi: 10.1016/j.cgh.2011.08.028 Montano-LozaAJ Meza-JuncoJ PradoCM LieffersJR BaracosVE BainVG Muscle wasting is associated with mortality in patients with cirrhosis Clin Gastroenterol Hepatol 2012 10 166 73 173.e1 10.1016/j.cgh.2011.08.028 Open DOISearch in Google Scholar

37. Lucidi C, Lattanzi B, Di Gregorio V, Incicco S, D’Ambrosio D, Venditti M, et al. A low muscle mass increases mortality in compensated cirrhotic patients with sepsis. Liver Int 2018; 38: 851–7. doi: 10.1111/liv.13691 LucidiC LattanziB Di GregorioV InciccoS D’AmbrosioD VendittiM A low muscle mass increases mortality in compensated cirrhotic patients with sepsis Liver Int 2018 38 851 7 10.1111/liv.13691 Open DOISearch in Google Scholar

38. Chang KV, Chen JD, Wu WT, Huang KC, Lin HY, Han DS. Is sarcopenia associated with hepatic encephalopathy in liver cirrhosis? A systematic review and meta-analysis. J Formos Med Assoc 2019; 118: 833–42. doi: 10.1016/j.jfma.2018.09.011 ChangKV ChenJD WuWT HuangKC LinHY HanDS Is sarcopenia associated with hepatic encephalopathy in liver cirrhosis? A systematic review and meta-analysis J Formos Med Assoc 2019 118 833 42 10.1016/j.jfma.2018.09.011 Open DOISearch in Google Scholar

39. Lattanzi B, D’Ambrosio D, Merli M. Hepatic encephalopathy and sarcopenia: two faces of the same metabolic alteration. J Clin Exp Hepatol 2019; 9: 125–13. doi: 10.1016/j.jceh.2018.04.007 LattanziB D’AmbrosioD MerliM Hepatic encephalopathy and sarcopenia: two faces of the same metabolic alteration J Clin Exp Hepatol 2019 9 125 13 10.1016/j.jceh.2018.04.007 Open DOISearch in Google Scholar

40. Dhaliwal A, Larson D, Hiat M, Muinov LM, Harrison WL, Sayles H, et al. Impact of sarcopenia on mortality in patients undergoing liver re-transplantation. World J Hepatol 2020; 12: 807–15. doi: 10.4254/wjh.v12.i10.807 DhaliwalA LarsonD HiatM MuinovLM HarrisonWL SaylesH Impact of sarcopenia on mortality in patients undergoing liver re-transplantation World J Hepatol 2020 12 807 15 10.4254/wjh.v12.i10.807 Open DOISearch in Google Scholar

41. Lee CM, Kang BK, Kim M. Radiologic definition of sarcopenia in chronic liver disease. Life 2021; 11: 86. doi: 10.3390/life11020086 LeeCM KangBK KimM Radiologic definition of sarcopenia in chronic liver disease Life 2021 11 86 10.3390/life11020086 Open DOISearch in Google Scholar

42. Meeks AC, Madill J. Sarcopenia in liver transplantation: a review. Clin Nutr ESPEN 2017; 22: 76–80. doi: 10.1016/j.clnesp.2017.08.005 MeeksAC MadillJ Sarcopenia in liver transplantation: a review Clin Nutr ESPEN 2017 22 76 80 10.1016/j.clnesp.2017.08.005 Open DOISearch in Google Scholar

43. van Vugt JL, Levolger S, de Bruin RW, van Rosmalen J, Metselaar HJ, IJzermans JN. Systematic review and meta-analysis of the impact of computed tomography-assessed skeletal muscle mass on outcome in patients awaiting or undergoing liver transplantation. Am J Transplant 2016; 16: 2277–92. doi: 10.1111/ajt.13732 van VugtJL LevolgerS de BruinRW van RosmalenJ MetselaarHJ IJzermansJN Systematic review and meta-analysis of the impact of computed tomography-assessed skeletal muscle mass on outcome in patients awaiting or undergoing liver transplantation Am J Transplant 2016 16 2277 92 10.1111/ajt.13732 Open DOISearch in Google Scholar

44. Yao J, Zhou X, Yuan L, Niu LY, Zhang A, Shi H, et al. Prognostic value of the third lumbar skeletal muscle mass index in patients with liver cirrhosis and ascites. Clin Nutr 2020; 39: 1908–13. doi: 10.1016/j.clnu.2019.08.006 YaoJ ZhouX YuanL NiuLY ZhangA ShiH Prognostic value of the third lumbar skeletal muscle mass index in patients with liver cirrhosis and ascites Clin Nutr 2020 39 1908 13 10.1016/j.clnu.2019.08.006 Open DOISearch in Google Scholar

45. Kappus MR, Wegermann K, Bozdogan E, Patel YA, Janas G, Shropshire E, et al. Use of skeletal muscle index as a predictor of wait-list mortality in patients with end-stage liver disease. Liver Transpl 2020; 26: 1090–9. doi: 10.1002/lt.25802 KappusMR WegermannK BozdoganE PatelYA JanasG ShropshireE Use of skeletal muscle index as a predictor of wait-list mortality in patients with end-stage liver disease Liver Transpl 2020 26 1090 9 10.1002/lt.25802 Open DOISearch in Google Scholar

46. Aby ES, Lee E, Saggi SS, Viramontes MR, Grotts JF, Agopian VG, et al. Pretransplant sarcopenia in patients with NASH cirrhosis does not impact rehospitalization or mortality. J Clin Gastroenterol 2019; 53: 680–5. doi: 10.1097/MCG.0000000000001109 AbyES LeeE SaggiSS ViramontesMR GrottsJF AgopianVG Pretransplant sarcopenia in patients with NASH cirrhosis does not impact rehospitalization or mortality J Clin Gastroenterol 2019 53 680 5 10.1097/MCG.0000000000001109 Open DOISearch in Google Scholar

47. Czigany Z, Kramp W, Lurje I, Miller H, Bednarsch J, Lang SA, et al. The role of recipient myosteatosis in graft and patient survival after deceased donor liver transplantation. J Cachexia Sarcopenia Muscle 2021; 12: 358–67. doi: 10.1002/jcsm.12669 CziganyZ KrampW LurjeI MillerH BednarschJ LangSA The role of recipient myosteatosis in graft and patient survival after deceased donor liver transplantation J Cachexia Sarcopenia Muscle 2021 12 358 67 10.1002/jcsm.12669 Open DOISearch in Google Scholar

48. Nelke C, Dziewas R, Minnerup J, Meuth SG, Ruck T. Skeletal muscle as potential central link between sarcopenia and immune senescence. EBioMedicine 2019; 49: 381–8. doi: 10.1016/j.ebiom.2019.10.034 NelkeC DziewasR MinnerupJ MeuthSG RuckT Skeletal muscle as potential central link between sarcopenia and immune senescence EBioMedicine 2019 49 381 8 10.1016/j.ebiom.2019.10.034 Open DOISearch in Google Scholar

49. Wakabayashi T, Shinoda M, Obara H, Kitago M, Yagi H, Abe Y, et al. Decreased incidence of acute cellular rejection in low-muscle-mass recipients after living-donor liver transplantation. Transplant Proc 2018; 50: 3626–34. doi: 10.1016/j.transproceed.2018.06.028 WakabayashiT ShinodaM ObaraH KitagoM YagiH AbeY Decreased incidence of acute cellular rejection in low-muscle-mass recipients after living-donor liver transplantation Transplant Proc 2018 50 3626 34 10.1016/j.transproceed.2018.06.028 Open DOISearch in Google Scholar

50. Bellido D, García-García C, Talluri A, Lukaski HC, García-Almeida JM. Future lines of research on phase angle: strengths and limitations. Rev Endocr Metab Disord 2023; 24: 563–83. doi: 10.1007/s11154-023-09803-7 BellidoD García-GarcíaC TalluriA LukaskiHC García-AlmeidaJM Future lines of research on phase angle: strengths and limitations Rev Endocr Metab Disord 2023 24 563 83 10.1007/s11154-023-09803-7 Open DOISearch in Google Scholar

51. Lee CM, Kang BK, Kim M. Radiologic definition of sarcopenia in chronic liver disease. Life 2021; 11: 86. doi: 10.3390/life11020086 LeeCM KangBK KimM Radiologic definition of sarcopenia in chronic liver disease Life 2021 11 86 10.3390/life11020086 Open DOISearch in Google Scholar

52. Kallwitz ER. Sarcopenia and liver transplant: the relevance of too little muscle mass. World J Gastroenterol 2015; 21: 10982–93. doi: 10.3748/wjg.v21.i39.10982 KallwitzER Sarcopenia and liver transplant: the relevance of too little muscle mass World J Gastroenterol 2015 21 10982 93 10.3748/wjg.v21.i39.10982 Open DOISearch in Google Scholar

53. Lindqvist C, Brismar TB, Majeed A, Wahlin S. Assessment of muscle mass depletion in chronic liver disease: dual-energy x-ray absorptiometry compared with computed tomography. Nutrition 2019; 61: 93–8. doi: 10.1016/j.nut.2018.10.031 LindqvistC BrismarTB MajeedA WahlinS Assessment of muscle mass depletion in chronic liver disease: dual-energy x-ray absorptiometry compared with computed tomography Nutrition 2019 61 93 8 10.1016/j.nut.2018.10.031 Open DOISearch in Google Scholar

54. Shenvi SD, Taber DJ, Hardie AD, Botstein JO, McGillicuddy JW. Assessment of magnetic resonance imaging derived fat fraction as a sensitive and reliable predictor of myosteatosis in liver transplant recipients. HPB (Oxford) 2020; 22: 102–8. doi: 10.1016/j.hpb.2019.06.006 ShenviSD TaberDJ HardieAD BotsteinJO McGillicuddyJW Assessment of magnetic resonance imaging derived fat fraction as a sensitive and reliable predictor of myosteatosis in liver transplant recipients HPB (Oxford) 2020 22 102 8 10.1016/j.hpb.2019.06.006 Open DOISearch in Google Scholar

55. Ahn H, Kim DW, Ko Y, Ha J, Shin YB, Lee J, et al. Updated systematic review and meta-analysis on diagnostic issues and the prognostic impact of myosteatosis: a new paradigm beyond sarcopenia. Ageing Res Rev 2021; 70: 101398. doi: 10.1016/j.arr.2021.101398 AhnH KimDW KoY HaJ ShinYB LeeJ Updated systematic review and meta-analysis on diagnostic issues and the prognostic impact of myosteatosis: a new paradigm beyond sarcopenia Ageing Res Rev 2021 70 101398 10.1016/j.arr.2021.101398 Open DOISearch in Google Scholar

56. Martin L, Birdsell L, Macdonald N, Reiman T, Clandinin MT, McCargar LJ, et al. Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J Clin Oncol 2013; 31:1539–47. doi: 10.1200/JCO.2012.45.2722 MartinL BirdsellL MacdonaldN ReimanT ClandininMT McCargarLJ Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index J Clin Oncol 2013 31 1539 47 10.1200/JCO.2012.45.2722 Open DOISearch in Google Scholar

57. Loosen SH, Schulze-Hagen M, Püngel T, Bündgens L, Wirtz T, Kather JN, et al. Skeletal muscle composition predicts outcome in critically Ill patients. Crit Care Explor 2020; 2: e0171. doi: 10.1097/CCE.0000000000000171 LoosenSH Schulze-HagenM PüngelT BündgensL WirtzT KatherJN Skeletal muscle composition predicts outcome in critically Ill patients Crit Care Explor 2020 2 e0171 10.1097/CCE.0000000000000171 Open DOISearch in Google Scholar

58. Kim HY, Jang JW. Sarcopenia in the prognosis of cirrhosis: going beyond the MELD score. World J Gastroenterol 2015; 21: 7637–47. doi: 10.3748/wjg.v21.i25.7637 KimHY JangJW Sarcopenia in the prognosis of cirrhosis: going beyond the MELD score World J Gastroenterol 2015 21 7637 47 10.3748/wjg.v21.i25.7637 Open DOISearch in Google Scholar

59. Francoz C, Prié D, Abdelrazek W, Moreau R, Mandot A, Belghiti J, et al. Inaccuracies of creatinine and creatinine-based equations in candidates for liver transplantation with low creatinine: impact on the model for end-stage liver disease score. Liver Transpl 2010; 16: 1169–77. doi: 10.1002/lt.22128 FrancozC PriéD AbdelrazekW MoreauR MandotA BelghitiJ Inaccuracies of creatinine and creatinine-based equations in candidates for liver transplantation with low creatinine: impact on the model for end-stage liver disease score Liver Transpl 2010 16 1169 77 10.1002/lt.22128 Open DOISearch in Google Scholar

60. Hamaguchi Y, Kaido T, Okumura S, Kobayashi A, Shirai H, Yao S, et al. Including body composition in MELD scores improves mortality prediction among patients awaiting liver transplantation. Clin Nutr 2020; 39: 1885–92. doi: 10.1016/j.clnu.2019.08.012 HamaguchiY KaidoT OkumuraS KobayashiA ShiraiH YaoS Including body composition in MELD scores improves mortality prediction among patients awaiting liver transplantation Clin Nutr 2020 39 1885 92 10.1016/j.clnu.2019.08.012 Open DOISearch in Google Scholar

61. Montano-Loza AJ, Duarte-Rojo A, Meza-Junco J, Baracos VE, Sawyer MB, Pang JX, et al. Inclusion of sarcopenia within MELD (MELD-Sarcopenia) and the prediction of mortality in patients with cirrhosis. Clin Transl Gastroenterol 2015; 6: e102. doi: 10.1038/ctg.2015.31 Montano-LozaAJ Duarte-RojoA Meza-JuncoJ BaracosVE SawyerMB PangJX Inclusion of sarcopenia within MELD (MELD-Sarcopenia) and the prediction of mortality in patients with cirrhosis Clin Transl Gastroenterol 2015 6 e102 10.1038/ctg.2015.31 Open DOISearch in Google Scholar

62. van Vugt JLA, Alferink LJM, Buettner S, Gaspersz MP, Bot D, Darwish Murad S, et al. A model including sarcopenia surpasses the MELD score in predicting waiting list mortality in cirrhotic liver transplant candidates: a competing risk analysis in a national cohort. J Hepatol 2018; 68: 707–14. doi: 10.1016/j.jhep.2017.11.030 van VugtJLA AlferinkLJM BuettnerS GasperszMP BotD Darwish MuradS A model including sarcopenia surpasses the MELD score in predicting waiting list mortality in cirrhotic liver transplant candidates: a competing risk analysis in a national cohort J Hepatol 2018 68 707 14 10.1016/j.jhep.2017.11.030 Open DOISearch in Google Scholar

63. Chedid MF, Picon RV, Chedid AD. ALBI and PALBI: novel scores for outcome prediction of cirrhotic outpatients awaiting liver transplantation. Ann Hepatol 2018; 17: 906–7. doi: 10.5604/01.3001.0012.7190 ChedidMF PiconRV ChedidAD ALBI and PALBI: novel scores for outcome prediction of cirrhotic outpatients awaiting liver transplantation Ann Hepatol 2018 17 906 7 10.5604/01.3001.0012.7190 Open DOISearch in Google Scholar

64. Bernardi N, Chedid MF, Grezzana-Filho TJM, Chedid AD, Pinto MA, Leipnitz I, et al. Pre-transplant ALBI grade 3 is associated with increased mortality after liver transplantation. Dig Dis Sci 2019; 64: 1695–704. doi: 10.1007/s10620-019-5456-6 BernardiN ChedidMF Grezzana-FilhoTJM ChedidAD PintoMA LeipnitzI Pre-transplant ALBI grade 3 is associated with increased mortality after liver transplantation Dig Dis Sci 2019 64 1695 704 10.1007/s10620-019-5456-6 Open DOISearch in Google Scholar

65. Miarka M, Gibiński K, Janik MK, Główczyńska R, Zając K, Pacho R, et al. Sarcopenia-the impact on physical capacity of liver transplant patients. Life 2021; 11: 740. doi: 10.3390/life11080740. MiarkaM GibińskiK JanikMK GłówczyńskaR ZającK PachoR Sarcopenia-the impact on physical capacity of liver transplant patients Life 2021 11 740 10.3390/life11080740 Open DOISearch in Google Scholar

66. European Association for the Study of the Liver. EASL Clinical Practice Guidelines on nutrition in chronic liver disease. J Hepatol 2019; 70: 172–93. doi: 10.1016/j.jhep.2018.06.024 European Association for the Study of the Liver EASL Clinical Practice Guidelines on nutrition in chronic liver disease J Hepatol 2019 70 172 93 10.1016/j.jhep.2018.06.024 Open DOISearch in Google Scholar

67. Maharshi S, Sharma BC, Sachdeva S, Srivastava S, Sharma P. Efficacy of nutritional therapy for patients with cirrhosis and minimal hepatic encephalopathy in a randomized trial. Clin Gastroenterol Hepatol 2016; 14: 454–60. e453. doi: 10.1016/j.cgh.2015.09.028 MaharshiS SharmaBC SachdevaS SrivastavaS SharmaP Efficacy of nutritional therapy for patients with cirrhosis and minimal hepatic encephalopathy in a randomized trial Clin Gastroenterol Hepatol 2016 14 454 60 e453 10.1016/j.cgh.2015.09.028 Open DOISearch in Google Scholar

68. Ebadi M, Bhanji RA, Mazurak VC, Montano-Loza AJ. Sarcopenia in cirrhosis: from pathogenesis to interventions. J Gastroenterol 2019; 54: 845–59. doi: 10.1007/s00535-019-01605-6 EbadiM BhanjiRA MazurakVC Montano-LozaAJ Sarcopenia in cirrhosis: from pathogenesis to interventions J Gastroenterol 2019 54 845 59 10.1007/s00535-019-01605-6 Open DOISearch in Google Scholar

69. Dasarathy S, Merli M. Sarcopenia from mechanism to diagnosis and treatment in liver disease. J Hepatol 2016; 65: 1232–44. doi: 10.1016/j.jhep.2016.07.040 DasarathyS MerliM Sarcopenia from mechanism to diagnosis and treatment in liver disease J Hepatol 2016 65 1232 44 10.1016/j.jhep.2016.07.040 Open DOISearch in Google Scholar

70. Berzigotti A, Albillos A, Villanueva C, Genesca J, Ardevol A, Augustin S, et al. Effects of an intensive lifestyle intervention program on portal hypertension in patients with cirrhosis and obesity: the SportDiet study. Hepatology 2017; 65: 1293–305. doi: 10.1002/hep.28992 BerzigottiA AlbillosA VillanuevaC GenescaJ ArdevolA AugustinS Effects of an intensive lifestyle intervention program on portal hypertension in patients with cirrhosis and obesity: the SportDiet study Hepatology 2017 65 1293 305 10.1002/hep.28992 Open DOISearch in Google Scholar

71. Stokes CS, Volmer DA, Grunhage F, Lammert F. Vitamin D in chronic liver disease. Liver Int 2013; 33: 338–52. doi: 10.1111/liv.12106 StokesCS VolmerDA GrunhageF LammertF Vitamin D in chronic liver disease Liver Int 2013 33 338 52 10.1111/liv.12106 Open DOISearch in Google Scholar

72. Miarka M, Gibiński K, Janik MK, Główczyńska R, Zając K, Pacho R, et al. Sarcopenia-the Impact on physical capacity of liver transplant patients. Life 2021; 11: 740. doi: 10.3390/life11080740 MiarkaM GibińskiK JanikMK GłówczyńskaR ZającK PachoR Sarcopenia-the Impact on physical capacity of liver transplant patients Life 2021 11 740 10.3390/life11080740 Open DOISearch in Google Scholar

73. Lei Q, Wang X, Zheng H, Bi J, Tan S, Li N. Peri-operative immunonutrition in patients undergoing liver transplantation: a meta-analysis of randomized controlled trials. Asia Pac J Clin Nutr 2015; 24: 583–90. doi: 10.6133/apjcn.2015.24.4.20. LeiQ WangX ZhengH BiJ TanS LiN Peri-operative immunonutrition in patients undergoing liver transplantation: a meta-analysis of randomized controlled trials Asia Pac J Clin Nutr 2015 24 583 90 10.6133/apjcn.2015.24.4.20 Open DOISearch in Google Scholar